These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 16275323)

  • 1. Expression and evaluation of RING finger proteins.
    Yang Y; Lorick KL; Jensen JP; Weissman AM
    Methods Enzymol; 2005; 398():103-12. PubMed ID: 16275323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation.
    Ghosh M; Huang K; Berberich SJ
    Biochemistry; 2003 Mar; 42(8):2291-9. PubMed ID: 12600196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53.
    Linares LK; Hengstermann A; Ciechanover A; Müller S; Scheffner M
    Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12009-14. PubMed ID: 14507994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ubiquitin-protein ligase activity of Hdm2 is inhibited by nucleic acids.
    Linares LK; Scheffner M
    FEBS Lett; 2003 Nov; 554(1-2):73-6. PubMed ID: 14596917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topors acts as a SUMO-1 E3 ligase for p53 in vitro and in vivo.
    Weger S; Hammer E; Heilbronn R
    FEBS Lett; 2005 Sep; 579(22):5007-12. PubMed ID: 16122737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An intact HDM2 RING-finger domain is required for nuclear exclusion of p53.
    Boyd SD; Tsai KY; Jacks T
    Nat Cell Biol; 2000 Sep; 2(9):563-8. PubMed ID: 10980695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase.
    Honda R; Yasuda H
    Oncogene; 2000 Mar; 19(11):1473-6. PubMed ID: 10723139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells.
    Yang Y; Ludwig RL; Jensen JP; Pierre SA; Medaglia MV; Davydov IV; Safiran YJ; Oberoi P; Kenten JH; Phillips AC; Weissman AM; Vousden KH
    Cancer Cell; 2005 Jun; 7(6):547-59. PubMed ID: 15950904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The contribution of the RING finger domain of MDM2 to cell cycle progression.
    Argentini M; Barboule N; Wasylyk B
    Oncogene; 2000 Aug; 19(34):3849-57. PubMed ID: 10951578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E3 ubiquitin ligase activity of the trifunctional ARD1 (ADP-ribosylation factor domain protein 1).
    Vichi A; Payne DM; Pacheco-Rodriguez G; Moss J; Vaughan M
    Proc Natl Acad Sci U S A; 2005 Feb; 102(6):1945-50. PubMed ID: 15684077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-terminal modifications regulate MDM2 dissociation and nuclear export of p53.
    Carter S; Bischof O; Dejean A; Vousden KH
    Nat Cell Biol; 2007 Apr; 9(4):428-35. PubMed ID: 17369817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrinsic ubiquitination activity of PCAF controls the stability of the oncoprotein Hdm2.
    Linares LK; Kiernan R; Triboulet R; Chable-Bessia C; Latreille D; Cuvier O; Lacroix M; Le Cam L; Coux O; Benkirane M
    Nat Cell Biol; 2007 Mar; 9(3):331-8. PubMed ID: 17293853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico analysis identifies a C3HC4-RING finger domain of a putative E3 ubiquitin-protein ligase located at the C-terminus of a polyglutamine-containing protein.
    Scior T; Luna F; Koch W; Sánchez-Ruiz JF
    Braz J Med Biol Res; 2007 Mar; 40(3):293-9. PubMed ID: 17334524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods for the functional genomic analysis of ubiquitin ligases.
    Li W; Chanda SK; Micik I; Joazeiro CA
    Methods Enzymol; 2005; 398():280-91. PubMed ID: 16275336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LNX functions as a RING type E3 ubiquitin ligase that targets the cell fate determinant Numb for ubiquitin-dependent degradation.
    Nie J; McGill MA; Dermer M; Dho SE; Wolting CD; McGlade CJ
    EMBO J; 2002 Jan; 21(1-2):93-102. PubMed ID: 11782429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.
    Honda R; Yasuda H
    EMBO J; 1999 Jan; 18(1):22-7. PubMed ID: 9878046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cellular RING finger protein PML is not a functional counterpart of the herpes simplex virus type 1 RING finger protein Vmw110.
    Everett RD; Maul GG; Orr A; Elliott M
    J Gen Virol; 1995 Apr; 76 ( Pt 4)():791-8. PubMed ID: 9049324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ubiquitin ligase COP1 is a critical negative regulator of p53.
    Dornan D; Wertz I; Shimizu H; Arnott D; Frantz GD; Dowd P; O'Rourke K; Koeppen H; Dixit VM
    Nature; 2004 May; 429(6987):86-92. PubMed ID: 15103385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53RFP, a p53-inducible RING-finger protein, regulates the stability of p21WAF1.
    Ng CC; Arakawa H; Fukuda S; Kondoh H; Nakamura Y
    Oncogene; 2003 Jul; 22(28):4449-58. PubMed ID: 12853982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification, expression, and assay of an oxidation-specific ubiquitin ligase, HOIL-1.
    Iwai K; Ishikawa H; Kirisako T
    Methods Enzymol; 2005; 398():256-71. PubMed ID: 16275334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.